Nurix Therapeutics Inc (NRIX) support and resistance · rev $54.5M
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
This page maps Nurix Therapeutics Inc (NRIX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
NRIX currently screens at market cap $1.77B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NRIX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NRIX quote page for the session range and the stock page for the full model.
Not investment advice.